Solstein Capital’s TELA Bio TELA Stock Holding History

Solstein Capital’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,385	Closed	-$31.8K	–	509
2025 Q2	$31.8K	Buy	+16,385	New	+$21.4K	0.02%	238

Other funds holding TELA

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Solstein Capital's TELA Position: Q3 2025 in Review

Solstein Capital sold out of TELA Bio (TELA) in Q3 2025, closing a stake of 16,385 shares — an estimated $31.8K sold.

Solstein Capital first reported a position in TELA in Q2 2025 and held it in 1 quarter. The position peaked at $31.8K in Q2 2025. 40 funds tracked by Wall St. Rank hold TELA as of Q3 2025.

Solstein Capital reported no remaining TELA Bio position as of Q3 2025 after selling out during the quarter.
Solstein Capital sold 16,385 TELA Bio shares in Q3 2025, an estimated $31.8K.
Solstein Capital first reported a position in TELA Bio in Q2 2025 and held it in 1 quarter.
Solstein Capital's TELA Bio position peaked at $31.8K in Q2 2025.
40 funds tracked by Wall St. Rank held TELA Bio as of Q3 2025.

Based on Solstein Capital's 13F filing for Q3 2025, filed 12 Nov 2025.